33 results on '"Tully, Karl H."'
Search Results
2. The Natural History of Renal-Cell Carcinoma with Sarcomatoid Differentiation, a Stage-by-Stage Analysis
3. A Multivariable Approach Using Magnetic Resonance Imaging to Avoid a Protocol-based Prostate Biopsy in Men on Active Surveillance for Prostate Cancer—Data from the International Multicenter Prospective PRIAS Study
4. The optimal number of induction chemotherapy cycles in clinically lymph node‐positive bladder cancer.
5. Changing the Prostate Cancer Detection Paradigm: Clinical Application of European Association of Urology Guideline–recommended Magnetic Resonance Imaging–based Risk Stratification in Men with Suspected Prostate Cancer
6. Risk of Dementia and Depression in Young and Middle-aged Men Presenting with Nonmetastatic Prostate Cancer Treated with Androgen Deprivation Therapy
7. Sex-specific Differences in the Quality of Treatment of Muscle-invasive Bladder Cancer Do Not Explain the Overall Survival Discrepancy
8. Quantifying the Overall Survival Benefit With Early Radical Cystectomy for Patients With Histologically Confirmed T1 Non–muscle-invasive Bladder Cancer
9. Treating BCG-Induced Cystitis with Combined Chondroitin and Hyaluronic Acid Instillations in Bladder Cancer.
10. An Empirical Survey on the Adaption of Neoadjuvant Chemotherapy in Bladder Cancer.
11. Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node‐positive bladder cancer.
12. Differences in survival and impact of adjuvant chemotherapy in patients with variant histology of tumors of the renal pelvis
13. Facility-Level Variation in Pelvic Lymphadenectomy During Radical Prostatectomy and Effect on Overall Survival in Men with High-Risk Prostate Cancer
14. Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma
15. Functional outcome after radical prostatectomy in 1313 patients: A single‐center study.
16. Temporal Trends in the Incidence of Testicular Cancer in the United States over the Past Four Decades
17. PD34-12 THE OPTIMAL NUMBER OF INDUCTION CHEMOTHERAPY CYCLES IN CLINICALLY LYMPH NODE-POSITIVE BLADDER CANCER.
18. MP08-01 PROSPECTIVE EVALUATION OF QUALITY OF LIFE, PSYCHOSOCIAL DISTRESS, FUNCTIONAL OUTCOMES, AND RETURN TO WORK IN 842 GERMAN BLADDER CANCER PATIENTS TWO YEARS AFTER RADICAL CYSTECTOMY AND URINARY DIVERSION.
19. Comparison of prostate cancer detection rates in patients undergoing MRI/TRUS fusion prostate biopsy with two different software‐based systems.
20. Prognostic Role of FGFR Alterations and FGFR mRNA Expression in Metastatic Urothelial Cancer Undergoing Checkpoint Inhibitor Therapy.
21. Identification of patients at risk for biochemical recurrence after radical prostatectomy with intra‐operative frozen section.
22. Risk of Immune-related Adverse Events in Melanoma Patients With Preexisting Autoimmune Disease Treated With Immune Checkpoint Inhibitors: A Population-based Study Using SEER-Medicare Data.
23. Probability of Prostate Cancer Diagnosis following Negative Systematic and Targeted MRI: Transrectal Ultrasound Fusion Biopsy: A Real-Life Observational Study.
24. Access denied: The relationship between patient insurance status and access to high‐volume hospitals.
25. Contemporary Treatment Patterns for Non-muscle-invasive Bladder Cancer: Has the Use of Radical Cystectomy Changed in the BCG Shortage Era?
26. Recovery from minimally invasive vs. open surgery in kidney cancer patients: Opioid use and workplace absenteeism.
27. Inequity in selective referral to high-volume hospitals for genitourinary malignancies.
28. Minimally invasive cancer surgery is associated with a lower risk of venous thromboembolic events.
29. Trends in Adherence to Thromboprophylaxis Guideline in Patients Undergoing Radical Cystectomy.
30. Parastomal Hernia Repair With 3-D Mesh Implants After Radical Cystectomy and Ileal Conduit Urinary Diversion - A Single-center Experience Using a Purpose Made Alloplastic Mesh Implant.
31. Temporal trends in the incidence of distant‐stage bladder cancer among young individuals.
32. Impact of tumor size on the oncological outcome of high-grade nonmuscle invasive bladder cancer - examining the utility of classifying Ta bladder cancer based on size.
33. The cost of obesity in radical cystectomy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.